Branden Moriarity Receives Early Innovator Award

The Office of the Vice President for Research and the university's Technology Commercialization office hosted their annual Inventor Recognition Event this past week. This year’s event recognized 455 University inventors whose technologies were licensed or patented between July 2016 and June 2018. Of the 455 recognized, Branden Moriarity, PhD, received the Early Innovator award.

Dr. Moriarity is currently working on harnessing the power of genome engineering in order to develop innovative immunotherapy approaches for treating highly lethal forms of cancer. Moriarity’s work, combined with that of his colleagues, was the foundation for B-MoGen Biotechnologies Inc., a University startup company launched in 2016. He currently serves as the company's chief scientific officer.

Share this post

Related News

  • Couple Returns to Minnesota, This Time to Make an Impact in Medicine

    Rahel Nardos, MD, MCR, and Damien Fair, PA-C, PhD, a married faculty duo are joining the University of Minnesota Medical School in different fields of medicine.Dr. Fair serves as the co-director of the Masonic Institute for the Developing Brain, and Dr. Nardos is an associate professor in the Department of Obstetrics, Gynecology and Women’s Health and serves as a urogynecologist and director for Global Women's Health at the Center for Global Health and Social Responsibility.

  • Long-standing ‘Hand Skills Day’ Simulation Goes Virtual

    With reduced exposure to the operating room during the COVID-19 pandemic, simulated orthopedic training has helped fill in learning gaps for residents, including the department’s James House, MD, Hand Skills Lectureship and Educational Workshop.